GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Personal Services » Grey Wolf Animal Health Corp (TSXV:WOLF) » Definitions » Total Liabilities

Grey Wolf Animal Health (TSXV:WOLF) Total Liabilities : C$36.77 Mil (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Grey Wolf Animal Health Total Liabilities?

Grey Wolf Animal Health's Total Liabilities for the quarter that ended in Dec. 2024 was C$36.77 Mil.

Grey Wolf Animal Health's quarterly Total Liabilities increased from Jun. 2024 (C$13.04 Mil) to Sep. 2024 (C$14.41 Mil) and increased from Sep. 2024 (C$14.41 Mil) to Dec. 2024 (C$36.77 Mil).

Grey Wolf Animal Health's annual Total Liabilities increased from Dec. 2022 (C$15.06 Mil) to Dec. 2023 (C$16.32 Mil) and increased from Dec. 2023 (C$16.32 Mil) to Dec. 2024 (C$36.77 Mil).


Grey Wolf Animal Health Total Liabilities Historical Data

The historical data trend for Grey Wolf Animal Health's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Grey Wolf Animal Health Total Liabilities Chart

Grey Wolf Animal Health Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Total Liabilities
32.16 15.06 16.32 36.77

Grey Wolf Animal Health Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.32 12.95 13.04 14.41 36.77

Grey Wolf Animal Health Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Grey Wolf Animal Health's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6.175+(25.455+1.7763568394003E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+5.141+0+0)
=36.77

Total Liabilities=Total Assets (A: Dec. 2024 )-Total Equity (A: Dec. 2024 )
=65.602-28.831
=36.77

Grey Wolf Animal Health's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=6.175+(25.455+1.7763568394003E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+5.141+0+0)
=36.77

Total Liabilities=Total Assets (Q: Dec. 2024 )-Total Equity (Q: Dec. 2024 )
=65.602-28.831
=36.77

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Grey Wolf Animal Health Total Liabilities Related Terms

Thank you for viewing the detailed overview of Grey Wolf Animal Health's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Grey Wolf Animal Health Business Description

Traded in Other Exchanges
N/A
Address
100 King Street West, Suite 6000, 1 First Canadian Place,, Toronto, ON, CAN, M5X 1E2
Grey Wolf Animal Health Corp operates as an animal health company. It focuses on improving the lives and well-being of vets and pets in Canada. It has two reportable operating segments: the Animal Health business unit selling, marketing, and distributing pharmaceutical, nutraceutical, and consumable products to veterinary clinics across Canada. and the Pharmacy business unit compounds pharmaceuticals, for equine use but also the bio-identical hormone replacement therapy market, all based on prescriptions received from veterinarians, physicians, and patients.
Executives
Angela Cechetto Senior Officer
Diane Bourassa Director
Shawn Douglas Aspden Director
Jill Terilee Angevine Director